رجوع
مُدرج أيضًا باسم
MCVEF
OTC
نطاق اليوم
KWD 16.55
KWD 21.54
نطاق 52 أسبوعًا
KWD 16.55
KWD 21.54
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 16.55
/
KWD 16.55
الإغلاق السابق
KWD 16.55
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 32.2 | 0.4 |
| P/B | 4.7 | 2.9 |
| ROE % | 15.5 | 3.7 |
| Net Margin % | 3.3 | 3.8 |
| Rev Growth 5Y % | 14.6 | 10.0 |
| D/E | 2.7 | 0.2 |
النقاط الرئيسية
Revenue grew 14.63% annually over 5 years — strong growth
Earnings grew 364.07% over the past year
ROE of 15.54% — decent returns on equity
Debt/Equity of 2.70 — high leverage
Generating 185.60M in free cash flow
P/E of 32.18 — premium valuation
النمو
Revenue Growth (5Y)
14.63%
Revenue (1Y)13.69%
Earnings (1Y)364.07%
FCF Growth (3Y)40.14%
الجودة
Return on Equity
15.54%
ROIC5.92%
Net Margin3.26%
Op. Margin6.55%
الأمان
Debt / Equity
2.70
Current Ratio0.70
Interest Coverage2.43
التقييم
P/E Ratio
32.18
P/B Ratio4.68
EV/EBITDA24.74
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.69% | Revenue Growth (3Y) | 16.69% |
| Earnings Growth (1Y) | 364.07% | Earnings Growth (3Y) | 109.84% |
| Revenue Growth (5Y) | 14.63% | Earnings Growth (5Y) | -6.59% |
| Profitability | |||
| Revenue (TTM) | 2.38B | Net Income (TTM) | 77.50M |
| ROE | 15.54% | ROA | 3.20% |
| Gross Margin | 23.16% | Operating Margin | 6.55% |
| Net Margin | 3.26% | Free Cash Flow (TTM) | 185.60M |
| ROIC | 5.92% | FCF Growth (3Y) | 40.14% |
| Safety | |||
| Debt / Equity | 2.70 | Current Ratio | 0.70 |
| Interest Coverage | 2.43 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 32.18 | P/B Ratio | 4.68 |
| P/S Ratio | 1.05 | PEG Ratio | 0.08 |
| EV/EBITDA | 24.74 | Dividend Yield | 0.01% |
| Market Cap | 2.49B | Enterprise Value | 3.85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.38B | 2.09B | 1.75B | 1.51B | 1.38B |
| Net Income | 77.50M | 16.70M | 17.60M | 11.80M | 101.80M |
| EPS (Diluted) | 0.51 | 0.11 | 0.12 | 0.08 | 0.69 |
| Gross Profit | 550.70M | 448.30M | 359.40M | 335.30M | 395.00M |
| Operating Income | 155.70M | 70.30M | 61.40M | 55.20M | 159.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.42B | 2.14B | 1.94B | 1.83B | 1.68B |
| Total Liabilities | 1.88B | 1.65B | 1.41B | 1.32B | 1.12B |
| Shareholders' Equity | 532.80M | 464.80M | 496.50M | 472.40M | 517.60M |
| Total Debt | 1.44B | 1.24B | 1.00B | 940.00M | 764.10M |
| Cash & Equivalents | 82.30M | 69.80M | 50.80M | 40.40M | 81.90M |
| Current Assets | 496.50M | 446.70M | 381.30M | 334.20M | 551.60M |
| Current Liabilities | 707.70M | 566.30M | 500.60M | 356.40M | 325.00M |